Health
AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021 – StreetInsider.com
NORTH CHICAGO, Ill., Nov. 1, 2021 /PRNewswire/ –Â AbbVie (NYSE: ABBV) today announced the presentation of new data on…
NORTH CHICAGO, Ill., Nov. 1, 2021 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced the presentation of new data on RINVOQ® (upadacitinib), SKYRIZI® (risankizumab) and HUMIRA® (adalimumab) across multiple rheumatic diseases at the American College…
Continue Reading
-
General18 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General22 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General21 hours agoJaguar Land Rover in UK pauses shipments to US
-
General17 hours agoAustralian share market set to dive as threat of US recession grows